ID: ALA2336376

Max Phase: Preclinical

Molecular Formula: C13H22N8O

Molecular Weight: 306.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@@H](N)COc1nc(NC(=N)N)c2ncn(C(C)C)c2n1

Standard InChI:  InChI=1S/C13H22N8O/c1-4-8(14)5-22-13-19-10(18-12(15)16)9-11(20-13)21(6-17-9)7(2)3/h6-8H,4-5,14H2,1-3H3,(H4,15,16,18,19,20)/t8-/m1/s1

Standard InChI Key:  OJNJHTYAWHGSHZ-MRVPVSSYSA-N

Associated Targets(Human)

Aurora kinase A/B 33 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 2/cyclin E1 1877 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 1/cyclin B1 1887 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 306.37Molecular Weight (Monoisotopic): 306.1917AlogP: 0.83#Rotatable Bonds: 6
Polar Surface Area: 140.75Molecular Species: BASEHBA: 7HBD: 4
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.57CX LogP: 0.93CX LogD: -1.66
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.46Np Likeness Score: -0.45

References

1. Dolečková I, Cesnek M, Dračinský M, Brynda J, Voller J, Janeba Z, Kryštof V..  (2013)  Synthesis and biological evaluation of guanidino analogues of roscovitine.,  62  [PMID:23399722] [10.1016/j.ejmech.2013.01.021]

Source